<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Overview of trial populations_1</title>
    <link href="data:image/x-icon;base64,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" rel="icon" type="image/x-icon">
    <style>@import "https://fonts.googleapis.com/css?family=Source+Sans+Pro:ital,wgth:0,400;0,700;1,400;1,700";body {  font-family: "Source Sans Pro", sans-serif;  margin: 40px;}@media screen {  #backToTop {    position: fixed;    bottom: 0px;    left: 50%;    transform: translateX(-50%);    border-radius: 4px 4px 0 0;    padding: 4px 12px 4px 12px;    background: #1f3c73;    font-weight: bold;  }  #backToTop a {    color: white;  }}@media print {  #backToTop {    display: none;  }}table {  width: fit-content;  border-collapse: collapse;}th {  font-weight: bold;  background: LightGray;}td, th {  border: 1px solid LightGray;  padding: 8px;  font-size: 14px;  vertical-align: top;}caption {  font-weight: bold;  font-size: large;  text-align: left;  padding: 8px;}h1 {  font-size:38.5px;}h2 {  font-size:31.5px;}h1 small, h3 {  font-size:24.5px;}h2 small, h4 {  font-size:17.5px;}h3 small, h4 small, h5 {  font-size:14px;}h6 {  font-size:11.9px;}a {  color: #002d64;  text-decoration: none;}.byline {  font-weight: bold;  color: #002D64;}.disclaimer {  font-style: italic;}figure, table.analysis {  width: fit-content;  display: block;  margin-block-start: 1em;  margin-block-end: 1em;  margin-inline-start: 40px;  margin-inline-end: 40px;}thead tr td, th, figcaption, caption {  font-weight: bold;  background: LightGray;}span.inserted {  background-color: #e5ffcd;}span.deleted {  background-color: #e5ffcd;  text-decoration: line-through;}span.marker-yellow {  background-color: #ffff80;}ol ol {  list-style-type: lower-alpha;}ol ol ol {  list-style-type: lower-roman;}</style>
  </head>
  <body>
    <div class="logo">
      <svg xmlns="http://www.w3.org/2000/svg" height="57" viewBox="0 0 1138.5 192" width="338" xml:space="preserve">
        <path d="M86 .5v33a63.3 63.3 0 0 0 0 125v33a96 96 0 0 1 0-191zM106 .5v33a63.3 63.3 0 0 1 0 125v33a96 96 0 0 0 0-191z" fill="#1f3c73"></path>
        <path d="M93 0h6v192h-6z" fill="#a53995"></path>
        <path d="M93 0h6v192h-6zM82 44h8v6h-8z" fill="#a53995"></path>
        <path d="M63 58h40v6H63zM69 73h30v6H69zM78 86h36v6H78zM63 100h42v6H63zM60 114h28v6H60zM88 128h15v6H88zM84 140l6 6-6 6-6-6z" fill="#a53995"></path>
        <g aria-label="Cochrane" fill="#1f3c73" stroke-width="3.368">
          <path d="M256.96 82.722q-7.366 0-13.564-3.413-6.198-3.414-9.97-10.06-3.683-6.737-3.683-16.528 0-9.701 3.772-16.528 3.863-6.917 10.15-10.51 6.378-3.682 13.743-3.682 5.66 0 10.15 2.335 4.492 2.246 7.456 5.3l-7.007 8.443q-2.245-2.066-4.76-3.323-2.426-1.347-5.57-1.347-3.952 0-7.275 2.245-3.234 2.246-5.21 6.468-1.886 4.221-1.886 10.15 0 8.982 3.862 14.013 3.863 5.03 10.33 5.03 3.593 0 6.378-1.617 2.874-1.617 5.03-3.863l7.006 8.264q-7.365 8.624-18.953 8.624zM302.86 82.722q-5.659 0-10.689-2.695-4.94-2.784-7.994-7.994-3.054-5.3-3.054-12.665 0-7.456 3.054-12.665 3.054-5.21 7.994-7.905 5.03-2.784 10.689-2.784t10.599 2.784q4.94 2.695 7.994 7.905 3.054 5.21 3.054 12.665 0 7.365-3.054 12.665-3.054 5.21-7.994 7.994-4.94 2.695-10.599 2.695zm0-10.689q4.042 0 6.108-3.413 2.066-3.504 2.066-9.252 0-5.839-2.066-9.252-2.066-3.413-6.108-3.413-4.132 0-6.198 3.413-1.976 3.413-1.976 9.252 0 5.749 1.976 9.252 2.066 3.413 6.198 3.413zM352.98 82.722q-6.198 0-11.228-2.695-4.94-2.784-7.905-7.994-2.874-5.3-2.874-12.665 0-7.456 3.234-12.665 3.233-5.21 8.533-7.905 5.3-2.784 11.408-2.784 4.132 0 7.276 1.347 3.234 1.348 5.749 3.413l-6.198 8.534q-3.144-2.605-6.018-2.605-4.761 0-7.636 3.413-2.784 3.413-2.784 9.252 0 5.749 2.784 9.252 2.875 3.413 7.186 3.413 2.156 0 4.222-.898 2.066-.988 3.773-2.335l5.21 8.623q-3.324 2.874-7.186 4.132-3.863 1.167-7.546 1.167zM375.53 81.644V18.677h13.204v15.45l-.629 7.994q2.515-2.245 5.839-4.131 3.413-1.977 7.904-1.977 7.276 0 10.51 4.85 3.323 4.762 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.091zM426.82 81.644V37.091h10.779l.898 7.815h.36q2.425-4.491 5.838-6.647 3.413-2.246 6.827-2.246 1.886 0 3.144.27 1.257.18 2.156.628l-2.156 11.408q-1.168-.359-2.336-.539-1.078-.18-2.515-.18-2.515 0-5.3 1.887-2.694 1.797-4.49 6.288v25.869zM471.28 82.722q-6.108 0-9.701-3.862-3.593-3.953-3.593-9.612 0-7.006 5.928-10.959 5.929-3.952 19.133-5.3-.18-2.964-1.796-4.67-1.527-1.797-5.21-1.797-2.785 0-5.659 1.078-2.874 1.078-6.108 2.964l-4.76-8.713q4.221-2.605 8.982-4.222 4.85-1.616 10.06-1.616 8.533 0 13.114 4.94 4.58 4.94 4.58 15.18v25.51h-10.778l-.898-4.581h-.36q-2.784 2.515-6.018 4.132-3.144 1.527-6.916 1.527zm4.491-10.24q2.246 0 3.863-.988 1.706-1.078 3.413-2.785v-7.814q-7.006.898-9.701 2.874-2.695 1.886-2.695 4.491 0 2.156 1.348 3.234 1.437.988 3.772.988zM507.39 81.644V37.091h10.779l.898 5.659h.36q2.874-2.695 6.287-4.671 3.503-2.066 7.995-2.066 7.275 0 10.509 4.85 3.323 4.761 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.09zM578.71 82.722q-6.378 0-11.498-2.785-5.12-2.784-8.084-7.994-2.964-5.21-2.964-12.575 0-7.276 2.964-12.486 3.054-5.21 7.904-7.994 4.85-2.875 10.15-2.875 6.378 0 10.51 2.875 4.221 2.784 6.287 7.635 2.156 4.76 2.156 10.869 0 1.706-.18 3.413-.18 1.617-.36 2.425h-26.677q.898 4.85 4.042 7.186 3.144 2.246 7.545 2.246 4.761 0 9.612-2.964l4.4 7.994q-3.412 2.335-7.634 3.683-4.222 1.347-8.174 1.347zm-9.88-28.205h16.078q0-3.683-1.796-6.018-1.707-2.426-5.66-2.426-3.053 0-5.479 2.156-2.425 2.066-3.143 6.288z"></path>
        </g>
        <g aria-label="Library" fill="#a53995" stroke-width="3.368">
          <path d="M236.48 168.68v-58.925h7.455v52.547h25.78v6.378zM279.42 168.68v-43.655h7.366v43.655zm3.773-52.637q-2.156 0-3.593-1.258-1.348-1.347-1.348-3.593 0-2.155 1.348-3.503 1.437-1.347 3.593-1.347 2.155 0 3.503 1.347 1.437 1.348 1.437 3.503 0 2.246-1.437 3.593-1.348 1.258-3.503 1.258zM320.82 169.76q-3.054 0-6.378-1.437-3.233-1.527-6.108-4.132h-.27l-.628 4.491h-5.928v-63.955h7.365v17.426l-.18 7.905q2.965-2.605 6.468-4.312 3.593-1.796 7.186-1.796 8.533 0 12.935 6.018 4.401 6.018 4.401 16.168 0 7.455-2.694 12.755-2.605 5.3-6.917 8.084-4.222 2.785-9.252 2.785zm-1.258-6.198q5.39 0 8.893-4.58 3.593-4.672 3.593-12.756 0-7.186-2.695-11.587-2.605-4.491-8.803-4.491-2.784 0-5.659 1.527-2.874 1.527-6.018 4.401v22.905q2.875 2.515 5.66 3.593 2.874.988 5.03.988zM351.19 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.899-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM390.26 169.76q-5.48 0-9.162-3.234-3.593-3.323-3.593-9.162 0-7.186 6.377-10.959 6.468-3.862 20.39-5.39 0-2.784-.808-5.299-.719-2.515-2.695-4.042-1.886-1.617-5.479-1.617-3.773 0-7.096 1.437-3.324 1.438-5.928 3.234l-2.875-5.12q3.054-1.976 7.456-3.773 4.49-1.886 9.7-1.886 7.995 0 11.588 4.94 3.593 4.851 3.593 13.026v26.768h-6.108l-.63-5.21h-.269q-3.054 2.515-6.736 4.401-3.593 1.886-7.725 1.886zm2.156-5.928q3.144 0 5.928-1.527 2.785-1.527 5.929-4.312v-12.126q-10.87 1.347-15.27 4.042-4.312 2.695-4.312 6.917 0 3.682 2.246 5.39 2.245 1.616 5.479 1.616zM425.47 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.898-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM459.6 187.45q-1.437 0-2.785-.27-1.257-.269-2.335-.628l1.437-5.839q.719.18 1.617.36.898.269 1.707.269 3.683 0 6.108-2.695 2.425-2.605 3.772-6.647l.988-3.233-17.516-43.745h7.636l8.892 24.163q.988 2.784 2.066 6.018 1.168 3.233 2.156 6.287h.36q.987-2.964 1.886-6.197.898-3.234 1.796-6.109l7.815-24.163h7.186l-16.438 47.248q-1.527 4.312-3.683 7.725-2.066 3.414-5.21 5.39-3.054 2.066-7.455 2.066z"></path>
        </g>
        <g aria-label="Trusted evidence." fill="#1f3c73" stroke-width="3.368">
          <path d="M710.25 61.723V30.141h-10.671v-3.773h25.869v3.773h-10.671v31.582zM728.9 61.723V35.53h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM755.25 62.37q-4.15 0-6.09-2.587-1.94-2.64-1.94-7.653v-16.6h4.473v16.007q0 3.665 1.132 5.336 1.185 1.67 3.772 1.67 2.048 0 3.611-1.024 1.617-1.078 3.45-3.395V35.53h4.42v26.193h-3.666l-.377-4.096h-.162q-1.832 2.156-3.88 3.45-2.048 1.293-4.743 1.293zM783.76 62.37q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.294-1.24 1.294-2.91 0-1.348-.917-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.186-1.832-.7-3.61-1.562-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862t3.61 2.102l-2.155 2.802q-1.347-1.024-2.803-1.67-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.809 2.049.808.754 2.101 1.347 1.294.539 2.749 1.132 1.886.7 3.719 1.617 1.832.862 3.018 2.371 1.24 1.455 1.24 3.934 0 2.102-1.132 3.88-1.078 1.78-3.234 2.857-2.102 1.078-5.228 1.078zM806.67 62.37q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306V39.141h-3.88V35.8l4.095-.27.54-7.33h3.718v7.33h7.06v3.61h-7.06v14.553q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.509-.216l1.455-.485.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM826.5 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM851.56 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.886 7.384 1.887 2.64 5.336 2.64zM893.92 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM915.97 61.723l-9.432-26.193h4.581l4.959 14.875 1.185 3.88q.647 1.94 1.24 3.827h.216q.592-1.886 1.185-3.827.647-1.94 1.186-3.88l4.958-14.875h4.366l-9.27 26.193zM935.48 61.723V35.53h4.42v26.193zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM957.68 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.887 7.384 1.886 2.64 5.335 2.64zM989.26 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1005.4 61.723V35.53h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42V45.715q0-3.665-1.185-5.335t-3.773-1.671q-1.994 0-3.61 1.024-1.563 1.024-3.558 3.018v18.971zM1045.2 62.37q-3.45 0-6.252-1.617t-4.42-4.689q-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM1068.9 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.707 3.341 2.748 3.342 2.748 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.678q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1087.4 62.37q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Informed decisions." fill="#1f3c73" stroke-width="3.368">
          <path d="M699.58 124.7V89.345h4.473V124.7zM713.32 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM743.56 124.7v-22.582h-3.557v-3.341l3.557-.27v-4.15q0-3.988 1.832-6.306 1.887-2.371 5.821-2.371 1.24 0 2.371.27 1.132.215 1.995.592l-.97 3.396q-1.456-.647-2.965-.647-3.665 0-3.665 5.066v4.15h5.552v3.61h-5.552V124.7zM768.19 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69t-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.102 2.748 5.443 2.748zM787.21 124.7V98.507h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689V124.7zM805.91 124.7V98.507h3.665l.377 3.773h.162q1.724-1.887 3.772-3.126 2.048-1.294 4.366-1.294 3.018 0 4.689 1.348 1.724 1.293 2.533 3.664 2.048-2.21 4.15-3.61 2.101-1.402 4.473-1.402 4.042 0 5.982 2.641 1.994 2.587 1.994 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.665-1.671-2.91 0-6.575 4.042V124.7h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.719-1.67-2.91 0-6.575 4.042v18.97zM861.21 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM886.27 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.886 7.384 1.887 2.64 5.336 2.64zM926.96 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.125-.646-2.102 0-3.827 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.887 7.384 1.886 2.64 5.335 2.64zM958.54 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM985.01 125.35q-3.45 0-6.252-1.617-2.802-1.617-4.42-4.689-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM999.23 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM1019.3 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.371-5.281 2.426-2.156 6.683-2.156 2.426 0 4.528.862 2.101.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1035.1 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809t2.101.809q.863.808.863 2.102 0 1.347-.863 2.155-.808.755-2.101.755zM1058.5 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69-2.748 1.616-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.101 2.748 5.443 2.748zM1077.5 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM1113.9 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862 2.102.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1131.9 125.35q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Better health." fill="#a53995" stroke-width="3.368">
          <path d="M699.58 187.95v-35.355h10.509q3.61 0 6.306.862 2.748.863 4.257 2.749 1.563 1.886 1.563 5.012 0 2.64-1.347 4.797-1.294 2.102-3.827 2.91v.216q3.18.592 5.174 2.694 2.048 2.102 2.048 5.767 0 3.45-1.724 5.767-1.671 2.317-4.69 3.449-3.017 1.132-7.005 1.132zm4.473-20.318h5.228q4.527 0 6.521-1.563 1.994-1.563 1.994-4.258 0-3.072-2.101-4.365-2.048-1.294-6.198-1.294h-5.444zm0 16.761h6.144q4.581 0 7.114-1.67 2.533-1.725 2.533-5.282 0-3.288-2.533-4.797-2.479-1.563-7.114-1.563h-6.144zM741.46 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM765.28 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM782.42 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM802.25 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM818.36 187.95v-26.193h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324t-1.348-.108q-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM847.84 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM887.78 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.586 5.982zM909.18 188.6q-3.288 0-5.497-1.94-2.156-1.994-2.156-5.498 0-4.311 3.826-6.575 3.88-2.317 12.234-3.233 0-1.671-.485-3.18-.43-1.51-1.616-2.426-1.132-.97-3.288-.97-2.264 0-4.258.863-1.994.862-3.557 1.94l-1.724-3.072q1.832-1.186 4.473-2.264 2.695-1.131 5.82-1.131 4.797 0 6.953 2.964 2.156 2.91 2.156 7.814v16.061h-3.665l-.377-3.125h-.162q-1.832 1.509-4.042 2.64-2.156 1.132-4.635 1.132zm1.294-3.557q1.886 0 3.556-.916 1.671-.916 3.557-2.587v-7.276q-6.52.808-9.162 2.425-2.587 1.617-2.587 4.15 0 2.21 1.348 3.234 1.347.97 3.287.97zM934.99 188.6q-2.48 0-3.61-1.509-1.079-1.563-1.079-4.42v-33.09h4.42v33.415q0 1.024.377 1.509.377.43.862.43h.377q.216-.053.593-.107l.593 3.341q-.431.216-1.024.324-.593.108-1.509.108zM952.29 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM962.26 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM993.9 188.6q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.563.916-2.479.97-.97 2.318-.97 1.294 0 2.21.97.97.917.97 2.48 0 1.455-.97 2.425-.917.916-2.21.916z"></path>
        </g>
      </svg>
    </div>
    <h1>Supplementary material 74 to: Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents</h1>
    <p>
      <span class="byline">Rajagopalan K, Hackl L, Pe&ntilde;a-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S</span>
      <br>
      <span class="doi"><a href="https://doi.org/10.1002/14651858.CD013227.pub2">https://doi.org/10.1002/14651858.CD013227.pub2</a></span>
    </p>
    <p>
      <span class="disclaimer">The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</span>
    </p>
    <div id="backToTop">
      <a href="#top">Back to top</a>
    </div>
    <h1>Overview of trial populations_1</h1>
    <div>
      <table>
        <tr>
          <th style="vertical-align: top;">
            <p>Trial ID (design)</p>
          </th><th style="vertical-align: top;">
            <p>Intervention(s) and comparator(s)</p>
          </th><th style="vertical-align: top;">
            <p>Description of power and sample size calculation</p>
          </th><th style="vertical-align: top;">
            <p>Screened/eligible<br>(N)</p>
          </th><th style="vertical-align: top;">
            <p>Randomised<br>(N)</p>
          </th><th style="vertical-align: top;">
            <p>Analysed (primary outcome)<br>(N)</p>
          </th><th style="vertical-align: top;">
            <p>Finishing trial<br>(N)</p>
          </th><th style="vertical-align: top;">
            <p>Randomised finishing trial<br>(%)</p>
          </th><th style="vertical-align: top;">
            <p>Follow-up<br>(extended follow-up)<sup>a</sup>
            </p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Amirsasan 2024</p>
            <p>Single-blind RCT</p>
            <p>Semi-experimental design</p>
            <p>Trial terminated early: no</p>
          </td><td style="vertical-align: top;">
            <p> I1: Iron supplementation (50 mg elemental iron daily)</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>"Sample size estimated based on G Power with power = 0.8 and alpha = 0.05."</p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p>33/30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>6 weeks</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: Iron + Sumac (50 mg iron + 1g sumac daily)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>10</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>10</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>10</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo (1g rice flour daily)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Lal 2024</p>
            <p>Parallel RCT</p>
            <p>Superiority trial<br>Trial terminated early: no</p>
          </td><td style="vertical-align: top;">
            <p>I1: Calcium (1000 mg Calcium gluconate per day)</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="4" style="text-align: center;vertical-align: top;">
            <p>Not mentioned how many were initially screened. Only that 60 were selected</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="5" style="vertical-align: top;">
            <p>6 weeks</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: Iron (10 mg Ferrous Sulphate + 1.5 mg Folic Acid per day)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I3: Combo (1000 mg Calcium gluconate in morning + 10 mg Ferrous Sulphate + 1.5 mg Folic Acid in evening)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo (100 mg sugar-coated ascorbate per day)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>60</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Long 2024</p>
            <p>Cluster RCT (class-based randomization)<br>Double-blind, placebo-controlled<br>Trial terminated early: no</p>
          </td><td style="vertical-align: top;">
            <p>I1: Physical activity (daily in-class breaks, weekly 45&ndash;60 min PE, dancing-to-music lessons)</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"Power calculations indicated that 1,096 children were needed per site (G*Power 3.1: f=0.10, alpha=0.05, power=0.80, 12 groups, 3 measurements). Assuming 10% dropout, the target was 1,320 children per site with 330 per arm."</p>
          </td><td rowspan="4" style="text-align: center;vertical-align: top;">
            <p>1320/1304</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>347</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>347</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="5" style="vertical-align: top;">
            <p>28 months (T1 = baseline, T2 = 9 months, T3 = 28 months)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: Multimicronutrient supplementation (daily modified MixMe&trade; tablet with β-carotene)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>325</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>325</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I3: PA + MMNS</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>297</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>297</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo control (usual class activity + placebo tablet)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>335</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>335</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>1304</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>1304</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>526</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>40.3</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Svensson 2024</p>
            <p>Parallel-group RCT<br>Quadruple-blind (caregivers, outcome assessors, researchers, statisticians)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Iron supplementation (1 mg/kg/day micronized microencapsulated ferric pyrophosphate)</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"With a power of 80% at an α of .05, assuming a 12-point SD and 20% dropout rate, a sample size of 220 was required to detect a 5-point difference in psychomotor development scores."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>1271 / &mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>111</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>104</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>104</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>93.7</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>36 months total (Bayley assessments at 12, 24, and 36 months)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo (maltodextrin)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>110</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>96</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>96</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.3</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>221</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>200</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>200</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90.5</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Csulak 2023</p>
            <p>Parallel-group RCT<br>Single-blind (participant-blinded)<br>Trial terminated early: no</p>
          </td><td style="vertical-align: top;">
            <p>I1: Iron group</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"Before the study, a desired effect size of 0.8 with a power (β) of 0.8 was selected. The minimum number of samples required was 52 (26 per group)."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>65 / 51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>3 months</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo group</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Pongpitakdamrong 2022</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous fumarate capsule</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
            <p> 
            </p>
            <p>"Power calculation was based on the results from the study of Konofal et al. of iron supplementation in ADHD16 for detecting a 7-point difference in the total ADHD score. Assuming type 1 error (alpha) of 0.05 and type 2 error (beta) of 0.2, the calculated sample size was 35 subjects for each group."</p>
            <p> 
            </p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p>116</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="4" style="text-align: center;vertical-align: top;">
            <p>12 wk</p>
          </td>
        </tr>
        <tr>
          <td rowspan="2" style="vertical-align: top;">
            <p>C1: no administration</p>
          </td>
        </tr>
        <tr>
          <td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>52</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>52</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>52</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Stelle 2022</p>
            <p>Parallel RCT<br>Double-blind (field staff blinded; statistician and dietitian unblinded)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Iron group</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Not reported.</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>103/101</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>49</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>49</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>98.0</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>98 days (14 weeks)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo group</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>101</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>99.0</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hoang 2021</p>
            <p>Parallel-group RCT<br>Double-blind (participant, teacher, outcome assessor)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Multiple Micronutrient Supplement</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Target sample size was 348 children, estimated to detect a 5 g/L difference in Hb with 88% power, assuming SD = 10 g/L, alpha = 0.05, correlation = 0.35, ICC = 0.06, design effect = 1.42, and 15% attrition.</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>3960 / 889</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>175</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>175</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>22 weeks (110 school days); no extended follow-up reported</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>172</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>172</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>347</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>306</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>347</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Zečkanović 2021</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: microencapsulated ferric iron (Qfer) syrup</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
            <p> 
            </p>
            <p>"The sample size was calculated through a sample size equation that projected the study to have 80% statistical power and accounted for a 15% drop-out rate and 5% type I error. We took into account the 3:1 randomization ratio and assumed that after 12 weeks of supplementation ferritin levels would be &gt;20 μg/L in 50% of the participants in the placebo arm and 85% of the participants in the &gt;Your&lt; Iron Syrup arm. A total of 92 participants were determined to be required (69 in &gt;Your&lt; Iron Syrup arm and 23 in the placebo arm)."</p>
            <p> 
            </p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p> 
            </p>
            <p>618</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>70</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>64</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>64</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>91.4</p>
          </td><td rowspan="4" style="text-align: center;vertical-align: top;">
            <p>2 mo</p>
          </td>
        </tr>
        <tr>
          <td rowspan="2" style="vertical-align: top;">
            <p>C1: placebo syrup</p>
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="text-align: center;vertical-align: top;">
            <p>24</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>21</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>21</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>94</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Tohidi 2021</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate capsule</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>54</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88</p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p>12 wk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo capsule</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>19</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>19</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>76</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>41</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>41</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Pasricha 2021</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: Iron syrup and placebo micronutrient powders</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>"We determined that a sample size of 3300 participants (1100 per group) would provide 80% power to detect a 2-point difference in cognitive composite score between each active intervention group and the placebo group immediately after completion of the assigned regimen, assuming a standard deviation of 15 points, a 20% loss to follow-up, and a two-sided type I error rate of 5%. With a Bonferroni-corrected two-sided alpha level of 0.025 for the comparisons between iron syrup and placebo and between multiple micro- nutrient powders and placebo, the trial would have at least 80% power to reject at least one of the two primary null hypotheses (no difference between iron syrup and placebo or between multiple micronutrient powders and placebo with respect to the primary outcome immediately after completion of the assigned regimen). In our previous systematic review of the effects of iron supplementation on cognitive development in young children, we estimated that iron supple- mentation would result in a 1.65-point higher cognitive composite score than placebo at the end of the intervention7; differences in the cognitive composite score of between 2 and 3 points in favor of iron supplementation have been re- ported in previous underpowered population trials.21 The current trial was thus powered to detect a minimum effect size of a 2-point between- group difference in the cognitive composite score immediately after completion of the assigned regimen; a 2-point difference is probably smaller than a clinically meaningful effect.&rdquo;</p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p>4040</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>1101</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>961</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>961</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>87.28</p>
          </td><td rowspan="4" style="text-align: center;vertical-align: top;">
            <p>3 mo</p>
          </td>
        </tr>
        <tr>
          <td rowspan="2" style="vertical-align: top;">
            <p>C1: placebo syrup and placebo micornutrient powders</p>
          </td>
        </tr>
        <tr>
          <td style="text-align: center;vertical-align: top;">
            <p>1100</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>970</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>970</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.18</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>2201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>1931</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>1931</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Parkin 2021</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate liquid</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"The following parameters were used: significance level of 5%, power of 80%, effect estimates for ELC ranging from 6-8 points based on previous iron studies,6,9 as well as parameters obtained from the pilot study including: pooled SD of the ELC (17.4), correlation (r) between the ELC at baseline and 4 month follow-up (0.89), and design factor (1 r2 = 0.21). For the primary end point at 4 months, a sample size of 56 children was required to detect a between-group difference of 6 points in the ELC; we aimed to enroll 60 chil- dren to account for the possibility of loss to follow up. For the secondary end point at 12 months, we aimed to retain at least 42 children to detect a between-group difference of 7 points in the ELC.&rdquo; </p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>220</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>31</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>28</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>28</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90.3</p>
          </td><td rowspan="3" style="text-align: center;vertical-align: top;">
            <p>4 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo liquid</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>29</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>93.1</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><td style="text-align: center;vertical-align: top;">
            <p>60</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>55</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>55</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Reynolds 2020</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate liquid</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"A sample size of 124 subjects was originally planned to provide greater than 80% power to detect a mean treatment-dependent improvement (change from baseline) in sleep latency of 30 minutes or in wake time after sleep onset of 20 minutes based on two-tailed testing at alpha = 0.025 and permitting up to 20% loss to follow-up. Based on observed standard errors for the treatment-dependent difference in 12-week change in SOL [SOL: sleep onset latency] and WASO [WASO: wake time after sleep onset], of 8.84 and 7.27 minutes, respectively, the study had 82% power to detect a 30-minunte [sic] improvement in SOL and 62% power to detect a 20-minute improvement in WASO. Power for the observed treatment-dependent differences was 14% and 11%, respectively."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>316/20</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>7</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>77.8</p>
          </td><td colspan="1" rowspan="3" style="text-align: center;vertical-align: top;">
            <p>3 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo liquid</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>81.8</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>20</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>20</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>16</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>80.0</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Johnstone 2019</p>
            <p>Parallel-group RCT<br>Triple-blind (participant, investigator, outcome assessor)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Micronutrients</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>To detect a minimum effect size of d = 0.6 with 80% power, α = 0.05 (two-tailed), 123 participants were required. Assuming two dropouts per arm per site, 135 participants were planned (3 sites, 3:2 randomization ratio, divisible by 15).</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>384 / 135</p>
            <p>(<i>Number eligible not explicitly mentioned; assumed part of screened pool</i>)</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>80</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>71</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>71</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.8</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>8 weeks (no extended follow-up reported)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>55</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>55</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>55</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100.0</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>135</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>126</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>126</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>93.3</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Rucklidge 2018</p>
            <p>Parallel-group RCT<br>Double-blind (participants, parents, teachers, outcome assessors)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Micronutrient formula</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Based on previous open-label pilot study:</p>
            <ul>
              <li>Effect size of 0.8&ndash;1.2 &rarr; estimated sample size = 36 per group to detect effect size &ge; 0.67</li>
              <li>80% power, α = 0.05 (two-tailed)</li>
              <li>Accounted for 10&ndash;15% attrition: aimed to recruit ~50 per group</li>
            </ul>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>Not fully detailed, but 93 participants randomized after eligibility confirmed</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>47</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>47</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>45</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95.7</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>10 weeks only<br>(No extended follow-up reported)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>46</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>46</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>44</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95.7</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>93</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>93</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>89</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>95.7</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bora 2019</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous ascorbate solution</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"We planned to enroll a total of 200 infants (50 infants in each of the 4 arms defined by mothers' anaemia status and infant's treatment assignment), expecting a 10% loss to follow-up based on our prior experience (The targeted <i>n </i>was 500/group (total = 2000)...The actual number of neonates enrolled was 363&ndash;383/group, with 9-mo outcome data of 305&ndash;318/group for iron status, 312&ndash;327/group for anthropometric measurements,and 350&ndash;368/group for doctor visits and hospitalizations. Using <i>n </i>values for iron status/anthropometry and α = 0.05, we had 80% power to detect a 16% or larger reduction in ID/IDA at 9 mo (RR = 0.84) and 0.23-SD differences in weight/length gain across groups. The 0.23-SD difference also applied to group differences in other continuous variables.). This sample size has 80% power at alpha = 0.05 to detect a 11.0g L<sup>-1</sup> difference in Hb and a 30 ng mL<sup>-1</sup> difference in serum-ferritin concentration at 6 months when comparing iron-supplemented with no iron-supplemented infants within the maternal anemic and nonanemic groups."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>3460/1237</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91.0</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91.0</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>200</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>180</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>182</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>91.0</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Deli 2017</p>
            <ul>
              <li>Cross-over RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: elemental iron tablet</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"According to a preliminary power analysis [a probability error of 0.05 and a statistical power of 90% for two groups and two measurements points (pre and post)], a sample size of 10 subjects per group was considered appropriate in order to detect statistically meaningful changes between groups."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>&mdash;/11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>10 wk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo tablet</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>11</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
              <br> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>11</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th><th style="vertical-align: top;">
            <p>&mdash;</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lozoff 2016</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: iron proteinsuccinylate solution</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"The targeted <i>n </i>was 500/group (total = 2000). The pregnancy RCT did not reach this target due to budgetary constraints and higher than expected attrition. The actual number of neonates enrolled was 363&ndash;383/group, with 9-mo outcome data of 305&ndash;318/group for iron status, 312&ndash;327/group for anthropometric measurements,and 350&ndash;368/group for doctor visits and hospitalizations. Using <i>n </i>values for iron status/anthropometry and α = 0.05, we had 80% power to detect a 16% or larger reduction in ID/IDA at 9 mo (RR = 0.84) and 0.23-SD differences in weight/length gain across groups. The 0.23-SD difference also applied to group differences in other continuous variables."</p>
          </td><td rowspan="2" style="text-align: center;vertical-align: top;">
            <p>2371/1482</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>746</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>629</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>648</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>86.9</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>9 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo solution</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>736</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>610</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>628</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85.3</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1482</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1239</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1276</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>86.1</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hamza 2014</p>
            <p>Randomized, controlled trial<br>Single-blind (participant)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Iron supplementation</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Based on a power of 0.8 and an alpha of 0.05, a sample size of 100 children (50 per group) was calculated to detect a significant difference in recurrent respiratory infections.</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>100 / 98</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>3 months</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100<br> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Singh 2014</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: iron + folic acid tablets</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>&mdash;/102</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50.0</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p> 
            </p>
            <p> 
            </p>
            <p>45 d</p>
            <p>
              <br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50.0<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: iron rich pearl millet ladoo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>15</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50.0</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>90</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>45</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>45</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>50.0</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Chen 2013</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate capsule</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"<b>&hellip;</b>our power calculation was based on detecting differences in the longitudinal prevalence of diarrhea (log-transformed) among the four groups. We simulated published values of the longitudinal prevalence of diarrhea, log-transformed these values (using a natural logarithmic scale), and estimated the SD (0.5; placebo group). Because a 5% absolute increase in the longitudinal prevalence of diarrhea is associated with an increased risk for mortality of 17% [84], we considered a 5% difference in the longitudinal prevalence of diarrhea among groups to be clinically meaningful. Therefore, we estimated that 30 children per group would ensure a power of 90% (α = 0.05) to detect &ldquo;between-group&rdquo; differences for the longitudinal prevalence of diarrhea (log-transformed). To allow for attrition over the duration of the study, we initially managed to recruit 120 children per group. Thus, using infectious illness as a secondary outcome, we also had sufficient power to evaluate the hypothesis. However, the primary outcome measurements including analysis indices before and after supplementation were obtained from 445 preschool children due to an unexpected, relatively high dropout rate for involvement in the present trial."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>&mdash;/500</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>112</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>98</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>98</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.5</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous sulphate capsule + vitamin A capsule<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>111<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>81.1<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>110</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>86.4<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: vitamin A capsule</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>112</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>104</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>104</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.9</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>445</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>387</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>387</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>87.0</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Zhang 2013</p>
            <p>Cluster Randomized Controlled Trial (RCT)<br>Unblinded (no placebo)<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: MMS group</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Power calculation using Optimal Design software:</p>
            <ul>
              <li>Effect size: 0.2 SD</li>
              <li>Power: 80%</li>
              <li>Alpha: 0.05</li>
              <li>Intra-cluster correlation: 0.15</li>
              <li>Pre/post correlation: 0.6</li>
              <li>10% expected loss to follow-up</li>
              <li>&rarr; Required: 50 students per school across 54 schools (24 treatment, 30 control)</li>
            </ul>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>3203 / 2730</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>24 schools</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>36 weeks (9 months)<br>No extended follow-up beyond the intervention</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Control group</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30 schools</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>3203</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>2730</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>2730</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>85.3</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Gokcay 2012</p>
            <ul>
              <li>Parallel / cluster / cross-over / factorial RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"Using existing data, we assumed prevalence of anaemia at 1 year of age as 30% in the control group and 5% in the supplemented group with a confidence interval of 95%.Given an α-level of 5% and power of 80%, we needed to obtain data on 43 infants in each group.To take into account an expected dropout rate of25%, we calculated that 60 infants would need to be enrolled in each group."</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;/120</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>60</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>51</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85.0</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>60</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>54</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>54</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90.0</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>120</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>105</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>105</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>87.5</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Cardenas 2011</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: iron + H. pylori eradication therapy</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"The sample size was calculated to meet the requirements of the study on levels of markers of iron stores. At the outset, we estimated that a study of at least 20 subjects in each of the arms would provide &gt;80% power to detect expected differences of &gt;40% in H pylori infection cure rates between arms with and without sequential therapy. Therefore, we estimated that a study of &gt;100 subjects across the 4 arms would provide enough statistical power to achieve this specific aim."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>1821/110</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>32</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>28</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>28</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.5</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>8 wk<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: iron + placebo eradication therapy</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>23<br> 
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>20<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>20</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.0<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo + H. pylori eradication therapy</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>29<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>23<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>23</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>79.3<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: placebo + placebo eradication therapy</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>19</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>19</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>73.1</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>110</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>90</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>90</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>81.8</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Kamble 2011</p>
            <ul>
              <li>Parallel</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate + folic acid tablet</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>209/108</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>54</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.6</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>3 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>54</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>50</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.6</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>108</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>92.6</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Moafi 2011</p>
            <p>Randomized, Double-Blind, Placebo-Controlled Trial<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Iron supplementation</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>Based on a power analysis, 72 students (36 per group) were enrolled to detect significant differences in educational performance, assuming an effect size of 0.5.</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>209 / 85</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>36</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>32</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>32</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.9</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>6 weeks</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>36</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>33</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>33</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91.7</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>72</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>65</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>65</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>90.3</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hacihamdioglu 2013</p>
            <ul>
              <li>Parallel</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;/65</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>35</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>77.1</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>2 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>30</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>26</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>86.7</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>65</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>53</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>53</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>81.5</p>
          </th>
        </tr>
        <tr>
          <td rowspan="6" style="vertical-align: top;">
            <p>Chang 2010</p>
            <p>Randomized, Double-Blind, Placebo-Controlled, Factorial Community Trial<br>Trial terminated early: No</p>
          </td><td style="vertical-align: top;">
            <p>I1: Zinc supplementation alone</p>
          </td><td rowspan="5" style="vertical-align: top;">
            <p>Target sample size of 1000 children, based on multiple-arm comparisons with 10% withdrawals, to detect a 20% reduction in diarrhea episodes per child-year, with 80% power and a significance level of 0.05.</p>
          </td><td rowspan="5" style="vertical-align: top;">
            <p>1473 / 1150</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>198</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>198</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>198</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td rowspan="6" style="vertical-align: top;">
            <p>26 weeks</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: Iron and zinc combined supplementation</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I3: Iron supplementation alone</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I4: Zinc supplementation and Iron separately</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>199</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>199</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>199</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: Placebo</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>Total</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1000</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1000</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>1000</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Ziegler 2009b</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate drops</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>"We hypothesized that regular consumption of iron would improve the iron status of infants. We felt that a difference of 12 &micro;g/L in mean plasma ferritin concentration at the end of the intervention would be convincing evidence of improved iron status. Our own data [85] indicated that the mean (&plusmn; SD) plasma ferritin concentration was 29.7 &plusmn; 16.5lg/L in 9-mo old infants. Therefore, 32 subjects per group were needed for a 2-sided test.</p>
            <p> 
            </p>
            <p>We increased the size of the control group by 50%, ie, to 48 to obtain a robust description of iron status among breastfed infants. Assuming an attrition rate of 35%, 172 infants needed to be enrolled to have 112 infants complete the intervention at 9mo of age. Attrition was only 21%, and 136 infants completed the intervention."</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>&mdash;/171</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>48</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>42</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>42</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.5</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>2 mo<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>59<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>56</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>56</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>94.9<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: medicinal iron cereal<sup>b</sup>
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>45</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>38</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>38</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>84.4</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>152</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>136</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>136</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>89.0</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Ziegler 2009a</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate + multivitamin drops</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>"Sample size was determined on the basis of PF concentration, which is proportional to iron stores, the endpoint of primary interest. We reasoned that for early iron supplementation to be clinically useful, it would have to augment iron stores, not only during supplementation but also for some time thereafter. We therefore chose PF concentration at 9 mo of age as the endpoint (ie, 3.5 mo after cessation of supplementation). Our own data [85] indicated that in 9-mo-old infants, PF concentration has an SD of 16.5 <i>μ</i>g/L. We considered a PF difference of 12 <i>μ</i>g/L to be clinically relevant. To detect a difference of 12 <i>μ</i>g/L at <i>α</i>= 0.05 and <i>β</i> = 0.20, we needed 31 subjects for a 2-sided test. With an estimated attrition rate of 15%, we needed to enroll 74 infants."</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;/75</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>37</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>31</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>31</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>83.8</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>8 mo (sample size calculation)</p>
            <p>4.5 mo (cessation of supplementation)</p>
            <p>17 mo (last assessment)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: multivitamin drops</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>38</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>32</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>32</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>84.2</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>75</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>63</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>63</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>84</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Hettiarachchi 2008</p>
            <ul>
              <li>Parallel / cluster / cross-over / factorial RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous fumarate capsules</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"...the sample size was calculated to be 180 per group to demonstrate a 15% reduction in the prevalence of anaemia with an <i>α</i> error of 5% and a <i>β</i> error of 10%. The calculated sample size was inflated to 200 per group assuming a 10&ndash;12% dropout rate during the follow-up period."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>&mdash;/821</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>202</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>193</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>193</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95.5</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>24 wk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I1: ferrous fumarate + zinc sulphate capsules</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>216</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>199</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>199</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.1<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo capsules</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>190</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>181</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>181</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>95.3<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: zinc sulphate capsules</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>213</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>94.4</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>821</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>774</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>774</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>94.3</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Engstrom 2008</p>
            <ul>
              <li>Parallel / cluster / cross-over / factorial RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate syrup</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>"The size of each group was calculated assuming prevalence of anaemia among 12-month-olds of 60%, difference in prevalence between intervention and control groups of 30%, 80% statistical power, 5% significance level, and an allocation ratio of 1:1. These parameters led to a minimal sample size of 120 children per group, or 145 per group assuming 20% losses to follow-up."</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>188</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>150</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>94</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>94</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous sulphate syrup weekly<sup>b</sup>
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>188</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>147<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>
              <b>total:</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>470</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>381</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>
              <b>&mdash;</b>
            </p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>
              <b>&mdash;</b>
            </p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Wasantwisut 2006</p>
            <ul>
              <li>Parallel / cluster / cross-over / factorial RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate syrup</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"A sample size of 130 infants/group was calculated to detect a difference in length-for-age (LAZ) [86] of 0.15 (with a SD of 0.9) with 95% CI and power of 0.90 among the groups, or to detect a difference in LAZ of 0.11 when using factorial analysis. Allowing for a dropout of 15%, a sample size of 150/group was included."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>&mdash;/674</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>166</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.2</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous sulphate + zinc sulphate syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>171</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>152</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>152</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.9<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: placebo syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>162</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>94.4<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: zinc sulphate syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>175</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>151</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>151</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>86.3</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>674</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>609</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>609</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>90.4</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Tielsch 2006</p>
            <ul>
              <li>Cluster RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: yes</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: iron + folic acid tablet</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>"To detect a reduction of 20% in overall mortality in the active treatment group with 80% power, a 2-sided type I error of 5%, a design effect of 1&middot;23, accounting for 10% loss to follow-up, and based on the assumption of no interaction of iron, folic acid, and zinc on mortality, we calculated that approximately 24 000 person-years in every row (column) of the marginal comparisons&mdash;ie, iron and folic acid versus placebo or zinc versus placebo&mdash;were required. However, at the second meeting of the data and safety monitoring board about 14 months into recruitment, we noted that the mortality rate of children was much lower than originally expected. We therefore recalculated the sample size estimates. The final number needed was calculated at about 33 000 person-years in every row (column) of the marginal comparisons."</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>&mdash;/26250</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>8128</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>3930</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>6717</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>82.6</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>until 36 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo tablet<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>8411<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>4413</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>7524</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>89.5<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: iron + folic acid tablet + zinc<sup>b</sup>
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>8951</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>4247</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>7292</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>81.5</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>25490</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>12590</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>21533</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>84.5</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Rosado 2006</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous fumarate tablet</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"The sample size was calculated to detect a 13% change in PbB (plasma lead) post supplementation, with an α-level of 0.05 and 80% power, according to the formula for a comparison of 2 means. A 15% loss to follow-up was taken into account in the calculations."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>724/602</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>151</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>138</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>141<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>93.4</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>12 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous fumarate tablet + zinc oxide tablet</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>152<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>127<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>130<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85.5<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo tablet<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>146<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>128<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>129<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.4<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: zinc oxide tablet</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>153</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>124</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>127<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>83.0</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>602</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>517</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>527</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>85.9</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bobonis 2006</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: iron + folic acid supplement, vitamin A</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td rowspan="2" style="vertical-align: top;">
            <p>&mdash;/4068</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>930</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: vitamin A</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>1542</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>2472</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Berger 2006</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate syrup</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>"The sample size was estimated to be about 140 subjects per group to detect a difference of 0.5s.d. in height-for-age (HAZ) or weight-for-age (WAZ) with a confidence level of 95% and a power of 0.90. Anticipating 30% dropouts a sample size of at least 200 subjects per group was required at baseline."</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>&mdash;/988<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>247</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>197</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>201</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>81.4</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>6 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous sulphate + zinc sulphate syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>247</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>187</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>190</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>76.9<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>247</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>195</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>198</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>80.2</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: zinc sulphate syrup</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>247</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>191<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>195<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>78.9<br> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>988</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>774</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>784</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>79.4</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>Untoro 2005</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate chewable tablet</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>"The sample size was calculated for the 4 country sites combined, based on the comparison of a decline in standardized weight for age from &minus;0.65 to &minus;0.95 for the intervention groups compared with a decline from &minus;0.65 to &minus;1.20 in the placebo (P) group. For a two-group, repeated measures ANOVA with 7 levels (mo 0 to 6) a sample size of 256 per group would provide the analysis with 80% power when the significance level is 5%. The aim was to include at least 70 infants per group (65 + 5 dropouts) in each country."</p>
          </td><td rowspan="4" style="vertical-align: top;">
            <p>&mdash;/356</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>72</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>69</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>70</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>97.2</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p>23 wk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: daily multiple micronutrient chewable tablet<sup>b</sup>
              <br> 
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>72<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>67<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>66<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>91.7<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I3: weekly multiple micronutrient chewable tablet<sup>b</sup>
              <br> 
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>70<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>59<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>61</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.1<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo chewable tablet<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>70</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>65</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>65</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>92.9</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>284</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>260</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>262</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>92.3</p>
          </th>
        </tr>
        <tr>
          <td rowspan="5" style="vertical-align: top;">
            <p>L&oacute;pez de Roma&ntilde;a 2005</p>
            <ul>
              <li>Factorial RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous fumarate chewable tablet</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>"The sample size was calculated for the 4 International Research on Infant Supplementation (IRIS, [87]) country sites combined, based on the comparison of a drop in standardized weight-for-age from &mdash;0.65 to &mdash;0.95 Z for the daily dose of multiple micronutrients (DMM) group compared with &mdash;0.65 to&mdash;1.20 in the P group. For a two-group repeated measures ANOVA with 7 levels (mo 0 to 6), a sample size of 256 per group will provide the analysis with 80% power when the significance level is 5%."</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>315/&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>82</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>74</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>90.2</p>
          </td><td colspan="1" rowspan="5" style="vertical-align: top;">
            <p> 
            </p>
            <p> 
            </p>
            <p> 
            </p>
            <p> 6 mo</p>
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: daily multiple micronutrient chewable tablet<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>73<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>53<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>72.6<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I3: weekly multiple micronutrient chewable tablet</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>76</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>65</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85.5</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: placebo chewable tablet<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>82</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>72<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>87.8<br> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>313</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>313</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>&mdash;</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Yurdak&ouml;k 2004</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Superiority trial</li>
              <li>Trial terminated early: yes/no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate suspension</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>"To decide on the sample size, we performed a preliminary study among our exclusively breast-fed infants who were 6 months of age (n = 10). The mean Hb value was found to be 10.9 g/dL (SD = 0.6). Using this preliminary study, it was calculated that a sample size of 19 infants per group was required (80% power; 5% significance level; two-tailed test) to detect a difference in Hb value of at least 0.5 g/dL between the control and intervention groups." [88]</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p>&mdash;/110</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>23</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>23</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>85.2</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>3 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>88.0<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>I2: ferrous sulphate suspension weekly<sup>b</sup>
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>27</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>22</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>81.5</p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>79</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>67</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>67</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>84.8</p>
          </th>
        </tr>
        <tr>
          <td rowspan="4" style="vertical-align: top;">
            <p>Tsalis 2004</p>
            <ul>
              <li>Parallel RCT</li>
              <li>Non-inferiority/superiority trial</li>
              <li>Trial terminated early: no</li>
            </ul>
          </td><td style="vertical-align: top;">
            <p>I1: ferrous sulphate capsule</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>&mdash;</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td><td colspan="1" rowspan="4" style="vertical-align: top;">
            <p>6 mo</p>
            <p> 
            </p>
            <p> 
            </p>
            <p>
              <br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C1: control</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>C2: six-day balanced diet rich in iron<sup>b</sup>
              <br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>14<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>100<br> 
            </p>
          </td>
        </tr>
        <tr>
          <th colspan="3" style="text-align: right;vertical-align: top;">
            <p>total:</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>42</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>42</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>42</p>
          </th><th style="text-align: center;vertical-align: top;">
            <p>100</p>
          </th>
        </tr>
        <tr>
          <th rowspan="3" style="vertical-align: top;">
            <p>
              <b>Grand totals</b>
            </p>
          </th><td style="vertical-align: top;">
            <p>
              <b>All interventions</b>
            </p>
          </td><td colspan="2" rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>12274</p>
          </td><td rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>9508<br> 
            </p>
          </td><td colspan="2" rowspan="3" style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>
              <b>All comparators</b>
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>13243</p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>10299<br> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>
              <b>All interventions and comparators</b>
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>25517<br> 
            </p>
          </td><td style="text-align: center;vertical-align: top;">
            <p>19807</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <h3>Footnotes</h3>
      <p>&mdash; denotes not reported</p>
      <p>
        <sup>a</sup>Follow-up under randomised conditions until end of trial ( (= duration of intervention + follow-up post intervention or identical to duration of intervention); extended follow-up refers to follow-up of participants once the original trial was terminated as specified in the power calculation.</p>
      <p>
        <sup>b</sup>Intervention arms will not be considered in this review and do not contribute to the grand totals.</p>
      <p>
        <b>ANOVA</b>: analysis of variance;<b> C:</b> comparator; <b>HAZ</b>: height-for-age Z-scores; <b>I:</b> intervention; <b>ID</b>: iron deficiency;<b> IDA</b>: iron deficiency anaemia; <b>mo</b>: month(s); <b>NA</b>: not applicable; <b>PbB</b>: blood lead concentration; <b>RCT</b>: randomised controlled trial; <b>RR</b>: risk ratio; <b>SD</b>: standard deviation; <b>SOL</b>: sleep onset latency; <b>WASO</b>: wake time after sleep onset; <b>WAZ</b>: weight-for-age Z-scores.</p>
    </div>
  </body>
</html>
